World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
136
Citations
90196
World Ranking
1946
National Ranking
1106

Research.com Recognitions

  • 1974 - Fellow of John Simon Guggenheim Memorial Foundation

Overview

Kenneth L. Davis is affiliated with the Icahn School of Medicine at Mount Sinai in the United States. Their research primarily spans psychology and biochemistry, genetics, and molecular biology, with a total of 36 and 21 publications in these fields respectively. Their work is often interdisciplinary, bridging molecular genetics with psychological theory and clinical applications.

Their main subfields of study include genetics, experimental and cognitive psychology, clinical psychology, social psychology, and applied psychology. These areas are reflected in the diverse topics that Kenneth L. Davis addresses through their research, including mental health research topics, genetic associations and epidemiology, genomics and rare diseases, personality traits and psychology, genomic variations and chromosomal abnormalities, personality disorders and psychopathology, and behavioral health and interventions.

Frequent co-authors collaborating with Kenneth L. Davis are Christian Montag, Tim B. Bigdeli, Farooq Amin, Ingrid Agartz, and Margot Albus. These collaborations illustrate a network of researchers working in overlapping areas of neuroscience, psychology, and genetics.

Some of the recent papers authored or co-authored by Kenneth L. Davis include:

  • Mapping genomic loci implicates genes and synaptic biology in schizophrenia, 2022, Nature
  • A Comparison of Ten Polygenic Score Methods for Psychiatric Disorders Applied Across Multiple Cohorts, 2021, Biological Psychiatry
  • Interaction Testing and Polygenic Risk Scoring to Estimate the Association of Common Genetic Variants With Treatment Resistance in Schizophrenia, 2022, JAMA Psychiatry
  • Linking individual differences in satisfaction with each of Maslow's needs to the Big Five personality traits and Panksepp's primary emotional systems, 2020, Heliyon
  • Schizophrenia risk conferred by rare protein-truncating variants is conserved across diverse human populations, 2023, Nature Genetics

Kenneth L. Davis publishes regularly in venues such as Personality Neuroscience, Neuropsychoanalysis, UNC Libraries, Nature, and Biological Psychiatry. Their recurring presence in specialized neuroscience and psychology journals relates closely to their interdisciplinary focus.

In addition to scholarly articles, Kenneth L. Davis has published books under Punctum Books, including two editions of Animal Emotions published in 2020.

Kenneth L. Davis's contributions have been recognized with a fellowship from the John Simon Guggenheim Memorial Foundation awarded in 1974.

Best Publications

  • Biological insights from 108 schizophrenia-associated genetic loci

    Stephan Ripke;Stephan Ripke;Benjamin M. Neale;Benjamin M. Neale;Aiden Corvin;James T. R. Walters

  • A new rating scale for Alzheimer's disease.

    Wilma G. Rosen;Richard C. Mohs;Kenneth L. Davis

  • Dopamine in Schizophrenia: A Review and Reconceptualization

    Kenneth L. Davis;René S. Kahn;Grant Ko;Michael Davidson

  • Correlation Between Elevated Levels of Amyloid β-Peptide in the Brain and Cognitive Decline

    Jan Näslund;Vahram Haroutunian;Richard Mohs;Kenneth L. Davis

  • The major genetic determinants of HIV-1 control affect HLA class I peptide presentation

    Pereyra F;Jia X;McLaren Pj

  • Mapping autism risk loci using genetic linkage and chromosomal rearrangements

    Peter Szatmari;Andrew D. Paterson;Lonnie Zwaigenbaum;Wendy Roberts

  • Serotonergic Studies in Patients with Affective and Personality Disorders: Correlates with Suicidal and Impulsive Aggressive Behavior

    Emil F. Coccaro;Larry J. Siever;Howard M. Klar;Gail Maurer

  • Modeling Linkage Disequilibrium Increases Accuracy of Polygenic Risk Scores

    Bjarni J. Vilhjálmsson;Jian Yang;Hilary K. Finucane;Alexander Gusev

  • Genome-wide expression analysis reveals dysregulation of myelination-related genes in chronic schizophrenia.

    Yaron Hakak;John R. Walker;Cheng Li;Wing Hung Wong

  • Effects of Rofecoxib or Naproxen vs Placebo on Alzheimer Disease Progression: A Randomized Controlled Trial

    Paul S. Aisen;Kimberly A. Schafer;Michael Grundman;Eric Pfeiffer

  • A psychobiological perspective on the personality disorders.

    Larry J. Siever;Kenneth L. Davis

  • Neuropsychopharmacology : The Fifth Generation of Progress

    Kenneth L. Davis;Dennis S. Charney;Joseph T. Coyle;Charles B. Nemeroff

  • Effects of inhaled nitric oxide in patients with acute respiratory distress syndrome: results of a randomized phase II trial. Inhaled Nitric Oxide in ARDS Study Group.

    R P Dellinger;J L Zimmerman;R W Taylor;R C Straube

  • Contribution of copy number variants to schizophrenia from a genome-wide study of 41,321 subjects

    Christian R Marshall;Daniel P Howrigan;Daniel P Howrigan;Daniele Merico;Bhooma Thiruvahindrapuram

  • White matter changes in schizophrenia: evidence for myelin-related dysfunction.

    Kenneth L. Davis;Daniel G. Stewart;Joseph I. Friedman;Monte Buchsbaum

  • A double-blind, placebo-controlled multicenter study of tacrine for Alzheimer's disease. The Tacrine Collaborative Study Group.

    K. L. Davis;Leon J. Thal;E. R. Gamzu;C. S. Davis

  • Neurochemical correlates of dementia severity in Alzheimer's disease: relative importance of the cholinergic deficits.

    Linda M. Bierer;Vahram Haroutunian;Steve Gabriel;Peter J. Knott

  • Overview: Toward a dysregulation hypothesis of depression.

    Larry J. Siever;Kenneth L. Davis

  • Neocortical Neurofibrillary Tangles Correlate With Dementia Severity in Alzheimer's Disease

    Linda M. Bierer;Patrick R. Hof;Dushyant P. Purohit;Linda Carlin

  • Cholinesterase Inhibitors in Alzheimer's Disease

    Kenneth L Davis

Frequent Co-Authors

Vahram Haroutunian
Vahram Haroutunian Icahn School of Medicine at Mount Sinai
Richard C. Mohs
Richard C. Mohs Eli Lilly (United States)
Jeremy M. Silverman
Jeremy M. Silverman Icahn School of Medicine at Mount Sinai
Larry J. Siever
Larry J. Siever Icahn School of Medicine at Mount Sinai
Philip D. Harvey
Philip D. Harvey University of Miami
Joseph D. Buxbaum
Joseph D. Buxbaum Icahn School of Medicine at Mount Sinai
Richard S.E. Keefe
Richard S.E. Keefe Duke University
Michael H. Davidson
Michael H. Davidson University of Chicago
Daniel P. Perl
Daniel P. Perl Uniformed Services University of the Health Sciences
Kenneth S. Kendler
Kenneth S. Kendler Virginia Commonwealth University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring alternative and related career pathways in healthcare is a smart move for those interested in Medicine. Many accredited nursing school online options now make it easier for students to enter the healthcare field, offering flexible schedules and affordable tuition. These programs are ideal for those looking to start working sooner or for those making a career change.

For registered nurses aiming to secure better roles or management positions, some of the cheapest online rn to bsn programs provide a cost-effective way to advance. Meanwhile, aspiring nurse educators or leaders might consider a phd in nursing, with online options to fit busy schedules.

If you don’t have a traditional nursing background, direct msn programs online offer short, intensive pathways for non-nurses to quickly transition into advanced nursing roles. Each of these online degrees opens doors to rewarding careers, supporting growing demand in U.S. healthcare.

Best Scientists Citing Kenneth L. Davis

Trending Scientists